Skip to main content
Sign In

An official website of the United States government

U.S. Department of Health & Human Services

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Distribution of REGEN‑COV by Jurisdiction

State/Territory-Coordinated Distribution of COVID‑19 Therapeutics

In response to the increased demand for COVID-19 therapeutics, the HHS Administration for Strategic Preparedness and Response transitioned to a State and Territory-coordinated Distribution System on September 13, 2021. To find out how many patient courses of COVID-19 therapeutics are being distributed to your state or territory, please see the current distribution tables.

View More

REGEN-COV was distributed by the federal government to states, territories, and federal entities from November 2020 through February 2021.

Distribution Weeks:

  • Distribution Cycle 1 - Week 1: November 24 - December 1, 2020
  • Distribution Cycle 2 - Week 2: December 2 -8, 2020
  • Distribution Cycle 3 - Week 3: December 9-15, 2020
  • Distribution Cycle 4 - Week 4: December 16-22, 2020
  • Distribution Cycle 5 - Weeks 5-6: December 23, 2020 - January 5, 2021
  • Distribution Cycle 6 - Weeks 7-8: January 6 - 19, 2021
  • Distribution Cycle 7 - Weeks 9-10: January 19 - February 2, 2021
States / Territories / Federal Entities Total
Patient Courses
Allocated		 Week 1
Phase 1
(patient courses) 		Week 2
Phase 1
(patient courses) 		Week 3
Phase 1
(patient courses) 		Week 4
Phase 1
(patient courses) 		Week 5-6
Phase 2
(patient courses) 		Week 7-8
Phase 2
(patient courses) 		Week 9-10
Phase 2
(patient courses)
All Jurisdictions (patient courses) 147,902 36,072 26,440 14,750 16,320 26,428 12,708 15,184
Alabama 2,014 456 330 180 180 508 170 190
Alaska 316 96 80 30 30 40 20 20
American Samoa 10 0 0 0 0 0 0 10
Arizona 3,550 720 550 320 400 710 340 510
Arkansas 1,444 384 270 130 130 250 120 160
Bureau of Prisons 336 0 0 0 0 192 72 72
California 15,308 2,328 2,160 1,240 1,380 4,120 1,620 2,460
Colorado 2,450 960 640 250 250 100 110 140
Commonwealth of the Northern Mariana Islands 10 0 0 0 0 10 0 0
Connecticut 1,404 384 250 140 140 240 90 160
Delaware 446 96 80 50 50 90 30 50
Department of Defense 3,116 216 400 1,000 1,000 300 100 100
Departmentof Health and Human Services 0 0 0 0 0 0 0 0
Department of State 0 0 0 0 0 0 0 0
District of Columbia 208 48 40 20 20 40 20 20
Federated States of Micronesia 0 0 0 0 0 0 0 0
Florida 6,658 1,608 1,220 560 560 1,210 630 870
Georgia 3,574 744 520 290 340 720 410 550
Guam 50 0 10 10 10 10 10 0
Hawaii 114 24 20 10 10 20 10 20
Idaho 790 240 170 80 80 120 40 60
Illinois 6,160 2,280 1,330 550 550 800 270 380
Indiana 4,228 1,248 820 370 370 600 570 250
Indian Health Service 4,416 216 400 1,000 1,000 600 600 600
Iowa 1,684 744 370 130 130 160 60 90
Kansas 1,726 576 360 150 150 250 100 140
Kentucky 2,830 840 590 270 270 450 190 220
Louisiana 4,168 456 280 160 160 1,630 902 580
Maine 228 48 30 20 20 40 20 50
Maryland 1,878 528 380 180 180 290 130 190
Massachusetts 1,964 504 340 230 240 450 200 0
Michigan 4,342 1,512 1,110 420 420 530 160 190
Minnesota 2,872 1,152 750 260 260 270 80 100
Mississippi 1,272 312 240 120 120 240 110 130
Missouri 2,812 1,032 610 240 240 390 150 150
Montana 664 264 150 60 60 70 20 40
National Institute of Health 0 0 0 0 0 0 0
Nebraska 1,146 456 260 100 100 120 40 70
Nevada 1,582 432 340 150 150 280 100 130
New Hampshire 392 72 60 40 50 80 40 50
New Jersey 3,466 864 680 320 320 570 220 492
New Mexico 1,162 432 240 100 100 150 60 80
New York 6,244 1,224 1,100 580 580 1,180 600 980
North Carolina 3,378 696 530 270 300 782 320 480
North Dakota 520 240 120 40 40 40 20 20
Ohio 6,010 1,680 1,320 560 640 990 350 470
Oklahoma 2,812 696 520 210 210 400 546 230
Oregon 816 216 180 80 80 130 50 80
Palau 0 0 0 0 0 0 0 0
Pennsylvania 5,518 1,368 1,130 570 590 1,060 360 440
Puerto Rico 340 0 100 40 40 80 30 50
Republic of Marshall Islands 0 0 0 0 0 0 0 0
Rhode Island 598 168 110 60 60 90 40 70
South Carolina 1,644 312 220 140 150 310 242 270
South Dakota 590 240 140 50 50 60 20 30
Tennessee 3,520 840 630 280 370 830 270 300
Texas 12,126 2,784 1,850 830 1,850 2,116 1,216 1,480
U.S. Virgin Islands 60 0 10 10 10 10 10 10
Utah 1,612 552 290 140 140 220 100 170
Vermont 94 24 10 10 10 10 10 20
Veterans Health Administration 3,016 216 400 1,000 1,000 300 0 100
Virginia 2,126 456 360 170 200 380 190 370
Washington 1,192 312 320 140 140 180 100 0
West Virginia 972 192 150 70 70 140 270 80
Wisconsin 3,550 1,440 790 290 290 430 130 180
Wyoming 374 144 80 30 30 40 20 30


Current Total Monoclonal Antibody Therapeutics Allocated and Delivered

Therapeutic Total Allocation (patient courses) Total Delivered (patient courses)
Bamlanivimab (through March 2, 2021) 798,591 664,691
REGEN-COV (through February 2, 2021) 147,902 96,923
All Monoclonal Antibody Therapeutics 946,493 761,614

Allocation Phases

  • Phase 1: allocation to hospitals and hospital-affiliated locations
  • Phase 2: allocation expanded to additional outpatients facilities

Prior COVID-19 Therapeutic Product Efforts

Date Range Threshold/Distribution/Allocation by Jurisdiction
April 25, 2022 - November 26, 2023 COVID-19 Therapeutics Threshold Determinations
September 13, 2021 - April 24, 2022 COVID-19 Therapeutics Distribution
November 9, 2020 - March 2, 2021 Bamlanivimab Distribution
July 6, 2020 - October 4, 2020 Allocation of Commercial Veklury (Remdesivir) (PDF)
May 4, 2020 - June 29, 2020 Allocation of Donated Veklury (Remdesivir)

COVID-19 Therapeutics Right-Nav

COVID-19 Therapeutics